Pityriasis Lichenoides Chronica, Role of Streptococcal Infection and Azithromycin

Pityriasis Lichenoides Clinical Trial

Official title: Role of Streptococcal Infection in the Etiopathogenesis of Pityriasis Lichenoides Chronica and the Therapeutic Efficacy of Azithromycin; a Randomized Controlled Trial

Status Not yet recruiting

Clinical Trial Summary

Primary outcome:

The primary outcome at end of study (EOS) is to compare the therapeutic efficacy of Azithromycin in the treatment of pityriasis lichenoides chronica (PLC) with that of a well-documented line of therapy namely narrow band ultra violet B (nbUVB).

Secondary outcomes:

1. To identify the possibility of streptococcal throat infection as a possible underlying etiology in PLC.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Pityriasis Lichenoides
• Streptococcal Infections

• NCT number: NCT03831269
• Study type: Interventional
• Source: Cairo University
• Contact: Amira Elbendary, MBBCh, MSc
• Phone: +201555668584
• Email: aelbendary@kasralainy.edu.eg
• Status: Not yet recruiting
• Phase: N/A
• Start date: February 2019
• Completion date: August 2020